QUVA PHARMA Trademark

Trademark Overview

On Tuesday, February 27, 2018, a trademark application was filed for QUVA PHARMA with the United States Patent and Trademark Office. The USPTO has given the QUVA PHARMA trademark a serial number of 87812712. The federal status of this trademark filing is REGISTERED as of Tuesday, November 6, 2018. This trademark is owned by QuVa Pharma, Inc.. The QUVA PHARMA trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of medications by pharmaceutical compounders
quva pharma

General Information

Serial Number87812712
Word MarkQUVA PHARMA
Filing DateTuesday, February 27, 2018
Status700 - REGISTERED
Status DateTuesday, November 6, 2018
Registration Number5599552
Registration DateTuesday, November 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements

Goods and ServicesCustom manufacture of medications by pharmaceutical compounders
NOT AVAILABLE"PHARMA"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, March 6, 2018
Primary Code040
First Use Anywhere DateThursday, May 28, 2015
First Use In Commerce DateThursday, May 28, 2015

Trademark Owner History

Party NameQuVa Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSugar Land, TX 77478
Party NameQuVa Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSugar Land, TX 77478
Party NameQuVa Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSugar Land, TX 77478

Trademark Events

Event DateEvent Description
Tuesday, March 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 12, 2018ASSIGNED TO EXAMINER
Thursday, June 21, 2018NON-FINAL ACTION WRITTEN
Thursday, June 21, 2018NON-FINAL ACTION E-MAILED
Thursday, June 21, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 25, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 25, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, July 1, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 16, 2018ASSIGNED TO LIE
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 6, 2018REGISTERED-PRINCIPAL REGISTER
Monday, November 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, December 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 2, 2018NEW APPLICATION ENTERED
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 4, 2024TEAS SECTION 8 & 15 RECEIVED

Related Keywords

pharma quva compounders pharmaceutical medications manufacture custom